Global Osteoporosis Treatment Market

Osteoporosis is a bone disease that develops when bone mineral density and bone mass decreases, or when the structure and strength of bone changes. This can lead to a decrease in bone strength that can increase the risk of fractures.
Osteoporosis is a “silent” disease because you typically do not have symptoms, and you may not even know you have the disease until you break a bone. Osteoporosis is the major cause of fractures in postmenopausal women and in older men. Fractures can occur in any bone but happen most often in bones of the hip, vertebrae in the spine, and wrist.
The global osteoporosis treatment market size was valued at USD 10.80 billion in 2018 and is projected to reach USD 20.68 billion by 2032, exhibiting a CAGR of 4.8% during the forecast period.

Market Dynamics
Drivers
Medical conditions: Some medical conditions that you may be able to treat or manage can increase the risk of osteoporosis, such as other endocrine and hormonal diseases, gastrointestinal diseases, rheumatoid arthritis, certain types of cancer, HIV/AIDS, and anorexia nervosa.
Lifestyle: A healthy lifestyle can be important for keeping bones strong. Factors that contribute to bone loss
Family history: Researchers are finding that your risk for osteoporosis and fractures may increase if one of your parents has a history of osteoporosis or hip fracture.

Restraints
High cost of treatment:
Side effects: Healthcare providers prescribe bisphosphonates to help treat osteoporosis and other conditions that affect the density and strength of your bones. There are oral and IV bisphosphonates. Common side effects include gastrointestinal issues, like reflux and esophagus inflammation. 

Opportunities:
State and Community Programs to Promote Bone Health for All Ages: National Bone Health Campaign, a national social marketing campaign to promote bone health in girls between the ages of 9 and 18 and thus reduce their risk of osteoporosis later in life. The initial focus of the effort is on girls 9 to 12 years of age, an age range that represents a “once-in-a-lifetime” opportunity to build skeletal mass.

Osteoporosis Medications:
Oral bisphosphonates 
Alendronate (Fosamax)
Risedronate (Actonel)
Ibandronate (Boniva)
 

Bisphosphonates 
Pamidronate (Aredia)
Zoledronic acid (Reclast, Zometa)

Osteoporosis Treatment Market Players

• Amgen Inc.
• Eli Lilly and Company
• Novartis International AG
• Gilead Sciences, Inc.
• Merck & Co., Inc.
• F. Hoffmann-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• GlaxoSmithKline PLC
• Sanofi
• Johnson & Johnson
• AbbVie Inc.
• Takeda Pharmaceutical Company Limited
• Sun Pharmaceutical Industries Ltd.
• Mylan N.V.
   

Market Segments:
By Drug Class

• Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid) 
• Hormone Replacement Therapy
• Parathyroid Hormone-Related Protein (PTHrP) Analog
• RANK ligand (RANKL) Inhibitor
• Selective Estrogen Receptor Modulator (SERMs) 
   

By Route of Administration

• Oral
• Parenteral
   

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies & Stores
• Online Pharmacies
   

By Geography
North America

• U.S.
• Canada
   

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe
   

Asia-Pacific

• India
• Japan
• China
• South Korea
• Rest of Asia-Pacific
   

Latin America

• Brazil
• Mexico
• Rest of Latin America
   

Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa
   

Osteoporosis Treatment Market Regional Analysis
August 2019, The biosimilar teriparatide biosimilar named terrosa by GEDEON Richter was launched in Europe after the patent expiry for its reference product. This product is indicated for the treatment of osteoporosis in postmenopausal women and in men with a high risk of fracture along with osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk of fracture.

January  2016, Taisho Pharmaceutical Co., Ltd., launched anti-inflammatory analgesic patch formulation LOQOA tape for the treatment of osteoarthritis pain inflammation. This tape provides powerful anti-inflammatory analgesic action.